ASK REDCHAT ANYTHING ABOUT BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI)
Listen to this Section
$0.75
-0.0445
(
-5.61% )
28.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| NurOwn (autologous MSC-NTF) (Debamestrocel)DetailsAmyotrophic lateral sclerosis, Neurodegenerative disease |
Phase 3 |
| NurOwn (autologous MSC-NTF) (Debamestrocel)DetailsMultiple sclerosis |
Failed |
Market Data
|
| Open |
$0.75 |
| Previous Close |
$0.79 |
| Volume |
28.1K |
| Market Cap |
$8.26M |
| Day Range |
$0.72 - $0.83 |
| 52 Week Range |
$0.46 - $1.33 |
| Shares Outstanding |
11.03M |
| Change % |
-5.61% |
| Net Change |
▼ -0.0445 |
| Insider Ownership |
-0.02% |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-1,253,790.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-10-02 |
Buy |
22000.00 |
Lebovits Chaim |
| 2024-07-24 |
Sale |
-63000.00 |
Dagher Ibrahim B. |
| 2024-06-25 |
Sale |
-30000.00 |
HARTOUNIAN HARTOUN |
| 2024-06-03 |
Sale |
-15000.00 |
Lebovits Chaim |
| 2024-05-23 |
Sale |
-25000.00 |
Lebovits Chaim |
| 2024-05-14 |
Sale |
-20000.00 |
Lebovits Chaim |
| 2024-05-07 |
Sale |
-135000.00 |
Lebovits Chaim |
| 2024-05-07 |
Sale |
-66300.00 |
Lebovits Chaim |
| 2024-04-25 |
Sale |
-15000.00 |
Lebovits Chaim |
| 2024-04-19 |
Sale |
-130000.00 |
Lebovits Chaim |